Table 1 General, demographic, and clinical findings in subjects with acute ischemic stroke and in subjects without ischemic stroke
Variables | Subjects with acute ischemic stroke (n 116) | Subjects without acute ischemic stroke (n 66) | p |
|---|---|---|---|
Sex (M/F) (n) | 59/57 | 29/37 | 0.43 |
Age (years) (mean ± ds) | 75.5 ± 11.6 | 73.7 ± 10.7 | 0.28 |
Diabetes (n/%) | 48 (41.37) | 30 (45.4) | 0.62 |
Hypertension (n/%) | 103 (87.9) | 53 (80) | 0.12 |
Hypercholesterolaemia (n/%) | 41 (35.34) | 27 (40.90) | 0.51 |
Hypertriclyceridaemia (n/%) | 26 (22.41) | 19 (28.78) | 0.32 |
Atrial fibrillation (n/%) | 53 (45.68) | 28 (42.46) | 0.67 |
Previous stroke (n/%) | 56 (48.27) | 12 (18.18) | < 0.0001 |
Glucose blood levels (mmol/L) | 7.99 ± 3.27 | 6.05 ± 1.91 | < 0.0001 |
SBP (mm/Hg) (mean ± ds) | 15 l.4 ± 27.4 | 132.1 ± 11.4 | < 0.0001 |
DBP (mm/Hg) (mean ± ds) | 82.05 ± 14.43 | 78.8 ± 6.6 | 0.094 |
WBC (mean ± ds) | 9448.7 ± 4978.17 | 7208.7 ± 2141.6 | < 0.0001 |
Neutrophil (%) (mean ± ds) | 72.3 ± 10.7 | 61.87 ± 9.5 | 0.32 |
ESR (mm/h) (mean ± ds) | 29.07 ± 17.5 | 14.7 ± 9.16 | < 0.0001 |
CRP (mg/dL) (mean ± ds) | 3.84 ± 5.56 | 1.7 ± 1.6 | 0.004 |
TOAST subtype | |||
LAAS | 45 (38.8) | ||
Lacunar | 27 (23.3) | ||
CEI | 40 (34.5) | ||
ODE | 4 (3.4) | ||
NIHSS (mean ± sd) | |||
SSSS (mean ± sd) | |||
CD4+ cells (%) (mean ± sd) | 50.21 ± 8.31 | 34.12 ± 6.81 | < 0.0001 |
CD4+CD28− (%) (mean ± sd) | 5.70 ± 2.33 | 2.78 ± 0.93 | < 0.0001 |
TNF-α (pg/ml) (mean ± sd) | 18.7 ± 3.28 | 12.34 ± 4.54 | 0.035 |
IL-6 (pg/ml) (mean ± sd) | 22.10 ± 12.21 | 4.22 ± 1.44 | < 0.0001 |